The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 5,661 | 5,971 | 5,991 | 6,019 |
| Net losses on financial instruments | -653 | -445 | -694 | - |
| Net losses (gains) on financial instruments | - | - | - | -550 |
| Gain on sale of business | 0 | 201 | - | - |
| Equity in net (earnings) losses of other invested assets | 398 | 1 | -33 | 293 |
| Depreciation and amortization | 1,546 | 1,393 | 1,745 | 1,675 |
| Deferred income taxes | -279 | -374 | -602 | -76 |
| Impairment of property and equipment | - | - | - | 7 |
| Impairment of property, equipment and right-of-use assets | 108 | 103 | 446 | - |
| Share-based compensation | 276 | 191 | 289 | 264 |
| Receivables, net | 2,526 | 683 | 1,762 | 2,510 |
| Other invested assets | 0 | 78 | 79 | -11 |
| Other assets | -57 | -824 | 675 | -120 |
| Policy liabilities | 228 | -1,840 | 147 | 2,254 |
| Unearned income | -15 | -113 | 290 | -42 |
| Accounts payable and other liabilities | -720 | -272 | 1,640 | 824 |
| Income taxes | -297 | 404 | -103 | -338 |
| Other, net | 4 | -39 | -7 | 66 |
| Net cash provided by operating activities | 4,290 | 5,808 | 8,061 | 8,399 |
| Purchases of investments | 15,026 | 17,986 | 16,236 | 24,946 |
| Proceeds from sale of investments | 13,324 | 16,547 | 10,596 | 11,988 |
| Maturities, calls and redemptions from investments | 1,771 | 2,025 | 2,940 | 10,620 |
| Changes in securities lending collateral | 385 | -73 | -78 | 301 |
| Purchases of subsidiaries, net of cash acquired | -88 | 4,809 | 1,552 | 649 |
| Proceeds from sales of subsidiaries, net of cash sold | 0 | 363 | - | - |
| Purchases of property and equipment | 1,116 | 1,256 | 1,296 | 1,152 |
| Other, net | 0 | 124 | 102 | 120 |
| Net cash used in investing activities | -1,344 | -5,167 | -5,572 | -4,560 |
| Net (repayments of) proceeds from commercial paper borrowings | - | - | - | -300 |
| Proceeds from long-term borrowings, net issuance costs | 2,991 | 7,710 | 2,574 | 3,071 |
| Repayments of long-term borrowings | 2,147 | 1,650 | 1,909 | 1,899 |
| Proceeds from short-term borrowings | 1,505 | 275 | 225 | 1,365 |
| Repayments of short-term borrowings | 1,720 | 135 | 265 | 1,375 |
| Changes in securities lending payable | 386 | -75 | -77 | 302 |
| Changes in bank overdrafts | 1,312 | -638 | 114 | 933 |
| Repurchase and retirement of common stock | 2,605 | 2,900 | 2,676 | 2,316 |
| Cash dividends | 1,529 | 1,508 | 1,395 | 1,229 |
| Proceeds from issuance of common stock under employee stock plans | 79 | 221 | 152 | 182 |
| Taxes paid through withholding of common stock under employee stock plans | 32 | 109 | 99 | 93 |
| Other, net | 22 | 2 | 7 | 41 |
| Net cash provided by (used in) financing activities | -1,738 | 1,193 | -3,349 | -1,318 |
| Effect of foreign exchange rates on cash and cash equivalents | -5 | -6 | -1 | -14 |
| Change in cash and cash equivalents | 1,203 | 1,828 | -861 | 2,507 |
| Cash and cash equivalents at beginning of period | 8,288 | - | 7,387 | 4,880 |
| Cash and cash equivalents at end of period | 9,491 | - | 6,526 | 7,387 |
Elevance Health, Inc. (ELV)
Elevance Health, Inc. (ELV)